ZYVERSA THERAPEUTICS, INC. Accrued Liabilities, Current
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Accrued Liabilities, Current of $3.30 million as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-05-13
- 2026-03-31: Accrued Liabilities, Current $3.30M.
- 2025-12-31: Accrued Liabilities, Current $2.73M; Accrued Liabilities, Current as first filed $2.61M.
- 2025-09-30: Accrued Liabilities, Current $2.96M.
- 2025-06-30: Accrued Liabilities, Current $2.92M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-03-31 | $3.30M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $2.73M 10-Q · filed 2026-05-13 | $2.61M 10-K · filed 2026-03-31 |
| 2025-09-30 | $2.96M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $2.92M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $2.40M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $1.89M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $2.26M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $1.68M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $1.45M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.75M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $2.78M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $2.28M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $2.11M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $2.05M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $1.63M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $775.46K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $828.46K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $200.25K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |